Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
Guggenheim Healthcare2nd Annual Neuro/Immunology Day on Monday, November 16, 2020
- Stifel 2020
Virtual Healthcare Conferenceon Tuesday, November 17, 2020at 4:40 pm ET Jefferies Virtual London Healthcare Conferenceon Thursday, November 19, 2020at 9:40 am ET( 2:40 pm GMT)
The above listed dates and times are subject to change. Details on company presentations and webcasts can be found on the “Investors” section of Xenon's website at www.xenon-pharma.com. When available, webcasts will be posted for replay following the event for 30 days.
We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered trademarks or trademarks of
Source: Xenon Pharmaceuticals Inc.